An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety

Liposomal nanomedicine represents a common and versatile carrier for the delivery of both lipophilic and hydrophilic drugs. However, the direct formulation of many chemotherapeutics into a liposomal system remains an enormous challenge. Using the topoisomerase I inhibitor 7-ethyl-10-hydroxycamptothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Linlin, Wu, Xinkai, Li, Tongyu, Wu, Yuan, Song, Liwei, Zhang, Wei, Yin, Luxi, Wu, Yuhui, Han, Weidong, Yang, Yunhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418717/
https://www.ncbi.nlm.nih.gov/pubmed/36131817
http://dx.doi.org/10.1039/d1na00838b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418717/
https://www.ncbi.nlm.nih.gov/pubmed/36131817
http://dx.doi.org/10.1039/d1na00838b

Ejemplares similares